Journal of Hepatology Hepatology
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma
The publisher did not provide an abstract — full text is available via the link below.
Journal of Hepatology Hepatology
The publisher did not provide an abstract — full text is available via the link below.